OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
Sam Altman's OpenAI is backing a new AI initiative from a group where John Kerry was a founding member that has voiced ...
OpenAI CEO Sam Altman envisions a future where AI surpasses human intelligence, emphasizing that human skills will still hold ...
Cathie Wood and her Ark Invest funds sold Oklo — the nuclear power startup backed by OpenAI head Sam Altman — and purchased ...
OpenAI is putting its focus on AI infrastructure with Stargate at a time when rivals like China's DeepSeek are closing the ...
OpenAI announced that it is launching a research preview of Operator, an AI agent that can take control of a browser and perform tasks.